The FDA has announced that Bayer HealthCare Pharmaceuticals Inc. has notified FDA that the company will begin removing the remaining Trasylol stock from the U.S. market and warehouses.
Trasylol
The FDA has announced that Bayer HealthCare Pharmaceuticals Inc. has notified FDA that the company will begin removing the remaining Trasylol stock from the U.S. market and warehouses.